Laboratory Corporation of America Holdings (NYSE:LH) Q4 2023

Laboratory Corporation of America Holdings beats earnings expectations. Reported EPS is $3.3, expectations were $3.29.

Related Keywords

Geneva , Genè , Switzerland , Washington , United States , Baystate , Massachusetts , California , China , Oregon , America , Jack Meehan , Glenn Eisenberg , Erin Wright , Kevin Caliendo , Christin Odonnell , Adam Schechter , Laboratory Corp , Fortrea Holdings Inc , Nephron Research , Legacy Health , Laboratory Corporation Of America Holdings Fourth Quarter , Laboratory Corporation Of America Holdings , Baystate Health , Central Laboratory , Morgan Stanley , America Holdings , Biopharma Laboratory Services , Central Lab , Laboratory Corporation , Call Transcript February , America Holdings Fourth Quarter , Full Year , Christino Donnell , Vice President , Investor Relations , Chief Executive Officer , Executive Vice President , Chief Financial , Western Massachusetts , Southwest Washington State , Providence Medical Groups , Hawthorne Effect , Biopharma Laboratory , Central Labs , Performing European Stocks So Far , Laboratory Corp Of America Holdings , Central Laboratories ,